Pathogen-Reduction for Platelet Concentrates

被引：0

作者：

Weber, C. F. ^{[1
]}

Heim, M. U. ^{[2
]}

机构：

[1] Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany

[2] Otto von Guericke Univ Hosp, Inst Transfus Med & Immunohematol, Magdeburg, Germany

来源：

CLINICAL LABORATORY | 2011年 / 57卷 / 5-6期

关键词：

FUNCTIONAL-CHARACTERISTICS; THERAPEUTIC-EFFICACY; APHERESIS PLATELETS; TREATED PLATELETS; SPRINT TRIAL; INACTIVATION; SAFETY; LIGHT; ULTRAVIOLET; TECHNOLOGY;

D O I：

暂无

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：293 / 295

页数：3

共 50 条

[41] Pathogen inactivation/reduction technologies for platelet transfusion: Where do we stand? [J].

Garraud, O. ;

Lozano, M. .

TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2018, 25 (03) :165-171

[42] Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction [J].

Fadeyi, Emmanuel A. ;

Wagner, Stephen J. ;

Goldberg, Corinne ;

Lu, Thea ;

Young, Pampee ;

Bringmann, Peter W. ;

Meier, Nathaniel M. ;

Namen, Andrew M. ;

Benjamin, Richard J. ;

Palavecino, Elizabeth .

TRANSFUSION, 2021, 61 (02) :641-648

[43] Bacterial inactivation of platelet concentrates with the THERAFLEX UV-Platelets pathogen inactivation system [J].

Gravemann, Ute ;

Handke, Wiebke ;

Mueller, Thomas H. ;

Seltsam, Axel .

TRANSFUSION, 2019, 59 (04) :1324-1332

[44] Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function [J].

Galan, Ana M. ;

Lozano, Miguel ;

Molina, Patricia ;

Navalon, Fulgencio ;

Marschner, Sussane ;

Goodrich, Raymond ;

Escolar, Gines .

TRANSFUSION, 2011, 51 (04) :808-815

[45] Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States [J].

Earnshaw, Stephanie ;

Beyhaghi, Hadi ;

McDade, Cheryl ;

Purser, Molly ;

Marriott, Robert ;

Daane, Lori ;

Le Coent, Virginie ;

Yang, Julie ;

Toback, Seth .

TRANSFUSION, 2021, 61 (10) :2885-2897

[46] Implementation of amotosalen plus ultraviolet A-mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion-transmitted infections [J].

Richard, Pascale ;

Pouchol, Elodie ;

Sandid, Imad ;

Aoustin, Laurent ;

Lefort, Caroline ;

Chartois, Anne-Gaele ;

Baima, Alexis ;

Malard, Lucile ;

Bacquet, Caroline ;

Ferrera-Tourenc, Virginie ;

Gallian, Pierre ;

Laperche, Syria ;

Bliem, Cathy ;

Morel, Pascal ;

Tiberghien, Pierre .

VOX SANGUINIS, 2024, 119 (03) :212-218

[47] Revisiting study design and methodology for pathogen reduced platelet transfusions: a round table discussion [J].

Heddle, Nancy M. ;

Cardoso, Marcia ;

van der Meer, Pieter F. .

TRANSFUSION, 2020, 60 (07) :1604-1611

[48] Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components [J].

Snyder, Edward L. ;

Wheeler, Allison P. ;

Refaai, Majed ;

Cohn, Claudia S. ;

Poisson, Jessica ;

Fontaine, Magali ;

Sehl, Mary ;

Nooka, Ajay K. ;

Uhl, Lynne ;

Spinella, Philip ;

Fenelus, Maly ;

Liles, Darla ;

Coyle, Thomas ;

Becker, Joanne ;

Jeng, Michael ;

Gehrie, Eric A. ;

Spencer, Bryan R. ;

Young, Pampee ;

Johnson, Andrew ;

O'Brien, Jennifer J. ;

Schiller, Gary J. ;

Roback, John D. ;

Malynn, Elizabeth ;

Jackups, Ronald ;

Avecilla, Scott T. ;

Lin, Jin-Sying ;

Liu, Kathy ;

Bentow, Stanley ;

Peng, Ho-Lan ;

Varrone, Jeanne ;

Benjamin, Richard J. ;

Corash, Laurence M. .

TRANSFUSION, 2022, 62 (07) :1365-1376

[49] Efficacy and safety of pathogen-reduced platelet concentrates in children with cancer: a retrospective cohort study [J].

Trakhtman, Pavel ;

Karpova, Oksana ;

Balashov, Dmitri ;

Kurnikova, Elena ;

Pirumova, Valentina ;

Starostin, Nikolay ;

Rumiantsev, Alexander .

TRANSFUSION, 2016, 56 :S24-S28

[50] Platelet concentrates: Balancing between efficacy and safety? [J].

Lozano, Miguel ;

Cid, Joan .

PRESSE MEDICALE, 2016, 45 (7-8) :E289-E298

← 1 2 3 4 5 →